Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

What We're Reading

  • What We're Reading
    Article Recommendations from Our Deputy and Senior Editors
    Cancer Immunol Res April 1 2017 5 (4) 271-271;

Obituary

  • Obituary
    George Klein (1925–2016) A Prescient, Luminous Voice
    Pramod K. Srivastava
    Cancer Immunol Res April 1 2017 5 (4) 272-272; DOI:10.1158/2326-6066.CIR-17-0105

Masters of Immunology

  • Masters of Immunology
    About the Masters
    Cancer Immunol Res April 1 2017 5 (4) 274-274; DOI:10.1158/2326-6066.CIR-17-0093

  • Masters of Immunology
    Masterful Antibodies: Checkpoint Blockade
    Nils Lonberg and Alan J. Korman
    Cancer Immunol Res April 1 2017 5 (4) 275-281; DOI:10.1158/2326-6066.CIR-17-0057

Meeting Report

  • Meeting Report
    Report on the FDA-AACR Immuno-oncology Drug Development Workshop
    Colleen Curran and Elad Sharon
    Cancer Immunol Res April 1 2017 5 (4) 282-285; DOI:10.1158/2326-6066.CIR-17-0087

Cancer Immunology Miniatures

  • Cancer Immunology Miniatures
    Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
    Marlene Garcia-Neuer, Melina E. Marmarelis, Sushrut R. Jangi, Jason J. Luke, Nageatte Ibrahim, Meredith Davis, Janice Weinberg, Hilary Donahue, Nancy Bailey, F. Stephen Hodi, Elizabeth L. Buchbinder and Patrick A. Ott
    Cancer Immunol Res April 1 2017 5 (4) 286-291; DOI:10.1158/2326-6066.CIR-16-0302

    Checkpoint blockade is becoming more widespread, so the timely and accurate diagnosis of immune-related colitis is increasingly important. By comparing diagnoses with colonoscopy data, CT scans were a fast, accurate, and non invasive mode of diagnosing ipilimumab-induced immune-related colitis.

  • Cancer Immunology Miniatures
    Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers
    Andrew R. Green, Mohammed A. Aleskandarany, Reem Ali, Eleanor Grace Hodgson, Suha Atabani, Karen De Souza, Emad A. Rakha, Ian O. Ellis and Srinivasan Madhusudan
    Cancer Immunol Res April 1 2017 5 (4) 292-299; DOI:10.1158/2326-6066.CIR-16-0195

    This study provides clinical evidence that the interplay between DNA repair, CD8+ T cells, and expression of PD-L1 and PD-1 can promote aggressive tumor phenotypes. XRCC1-directed personalization of immune checkpoint inhibitor therapy may be feasible in breast cancer.

Research Articles

  • Research Articles
    Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases
    Jiemiao Hu, Chantale Bernatchez, Liangfang Zhang, Xueqing Xia, Eugenie S. Kleinerman, Mien-Chie Hung, Patrick Hwu and Shulin Li
    Cancer Immunol Res April 1 2017 5 (4) 300-311; DOI:10.1158/2326-6066.CIR-16-0234

    NKG2D-mediated immune surveillance is crucial for inhibiting tumor growth and metastases, but tumors often downregulate NKG2D ligands. A therapeutic strategy to restore tumor-specific expression of NKG2D ligands on solid tumors was developed that induced tumor regression and increased survival.

  • Research Articles
    Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
    Guillermo De Velasco, Youjin Je, Dominick Bossé, Mark M. Awad, Patrick A. Ott, Raphael B. Moreira, Fabio Schutz, Joaquim Bellmunt, Guru P. Sonpavde, F. Stephen Hodi and Toni K. Choueiri
    Cancer Immunol Res April 1 2017 5 (4) 312-318; DOI:10.1158/2326-6066.CIR-16-0237

    A meta-analysis of immune checkpoint therapies showed a small but significant increase in the risk of developing key immune-related adverse events of any grade, as well as selected high-grade gastrointestinal and liver toxicities.

  • Research Articles
    Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
    Haley L. Peters, Satyendra C. Tripathi, Celine Kerros, Hiroyuki Katayama, Haven R. Garber, Lisa S. St. John, Lorenzo Federico, Ismail M. Meraz, Jack A. Roth, Boris Sepesi, Mourad Majidi, Kathryn Ruisaard, Karen Clise-Dwyer, Jason Roszik, Don L. Gibbons, John V. Heymach, Stephen G. Swisher, Chantale Bernatchez, Gheath Alatrash, Samir Hanash and Jeffrey J. Molldrem
    Cancer Immunol Res April 1 2017 5 (4) 319-329; DOI:10.1158/2326-6066.CIR-16-0141

    Lung cancer cells exposed to granulocyte serine proteases increased the presentation of both endogenous peptides and the exogenous, protease-derived, HLA-A2-restricted PR1 peptide. Circulating CTLs specific for these peptides were identified in lung cancer patients.

  • Research Articles
    Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers
    Satish K. Noonepalle, Franklin Gu, Eun-Joon Lee, Jeong-Hyeon Choi, Qimei Han, Jaejik Kim, Maria Ouzounova, Austin Y. Shull, Lirong Pei, Pei-Yin Hsu, Ravindra Kolhe, Fang Shi, Jiseok Choi, Katie Chiou, Tim H.M. Huang, Hasan Korkaya, Libin Deng, Hong-Bo Xin, Shuang Huang, Muthusamy Thangaraju, Arun Sreekumar, Stefan Ambs, Shou-Ching Tang, David H. Munn and Huidong Shi
    Cancer Immunol Res April 1 2017 5 (4) 330-344; DOI:10.1158/2326-6066.CIR-16-0182

    Triple-negative breast cancers (TNBCs) are often infiltrated by T cells. These tumors counteracted T-cell activity through hypomethylated IDO1 promoters and increased IDO1 expression in response to IFNγ, providing a rationale for treatment of TNBC with IDO inhibitors.

Back to top
PreviousNext
Cancer Immunology Research: 5 (4)
April 2017
Volume 5, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Editorial Board (PDF)

Sign up for alerts

Jump to

  • What We're Reading
  • Obituary
  • Masters of Immunology
  • Meeting Report
  • Cancer Immunology Miniatures
  • Research Articles
Advertisement
  • Most Cited
  • Most Read
Loading
  • Activity of Anti-CTLA-4 Isotypes in Antitumor Responses
  • Case Report: RNA CAR T Cells
  • PD-L1 in Triple-Negative Breast Cancer
  • Bevacizumab plus Ipilimumab
  • Vaccine-Induced Intratumoral Lymphoid Aggregates
More...
  • Home
  • Alerts
  • Feedback
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement